Navigation Links
AACR colorectal cancer conference to focus on screening, new treatments

PHILADELPHIA The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

Colorectal cancer is the third leading cause of cancer in men and women. While screening has brought mortality rates down, much work remains to be done.

"Colorectal cancer is still one of the deadliest cancers, and our current screening methods are not yet always efficient or complete," said Anil Rustgi, M.D., chief of gastroenterology, T. Grier Miller Professor of Medicine and Genetics, and American Cancer Society Professor at the University of Pennsylvania School of Medicine and a program chairperson of the AACR special conference.

Rustgi will host a press conference on Thursday, Oct. 28 at 1:00 p.m. ET in the Adams Room on the third floor of the Loews Hotel in Philadelphia. The press conference will feature the following new research:

  • Telomere Length Affects Colorectal Cancer Risk
  • New Colorectal Screening Test Measures DNA Methylation
  • FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability
  • Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

Reporters who cannot attend in person can participate using the following information:

Dial-in (U.S. and Canada): (888) 282-7404
Dial-in (International): (706) 679-5207
Access Code: 18304706

The American Association for Cancer Research Communications Department has also identified the following research as newsworthy:

  • Researchers Build Colony of Colon Cancer Stem Cells to Test New Approach to Therapy
  • Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme


Contact: Jeremy Moore
American Association for Cancer Research

Page: 1

Related biology news :

1. Hormone therapy associated with reduced colorectal cancer risk
2. Rural areas able to increase screening capacity for colorectal cancer
3. Study finds colorectal cancer rates increasing worldwide
4. Colorectal cancer
5. Cigarette smoking increases colorectal cancer risk
6. Breast cancer treatment resistance linked to signaling pathway
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. The dietary supplement genistein can undermine breast cancer treatment
9. Saliva proteins could help detection of oral cancer
10. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
11. Breakthrough optical technology to assess colon cancer risk, accuracy
Post Your Comments:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology: